Scarica l'app Stockscreener
0.2249
7.03%
-0.017
Precedente Chiudi:
$0.2419
Aprire:
$0.2693
Volume 24 ore:
21.50M
Relative Volume:
12.18
Capitalizzazione di mercato:
$14.96M
Reddito:
-
Utile/perdita netta:
$-17.78M
Rapporto P/E:
-0.4095
EPS:
-0.5492
Flusso di cassa netto:
$-10.52M
1 W Prestazione:
-4.66%
1M Prestazione:
-17.92%
6M Prestazione:
-63.85%
1 anno Prestazione:
-88.76%
Intervallo 1D:
$0.2212
$0.2694
Intervallo di 1 settimana:
$0.2212
$0.2694
Portata 52W:
$0.2201
$2.335
Fibrobiologics Inc Stock (FBLG) Company Profile
Nome
Fibrobiologics Inc
Settore
Industria
Telefono
281-671-5150
Indirizzo
455 E. MEDICAL CENTER BLVD, HOUSTON
Confronta FBLG con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
FBLG
Fibrobiologics Inc
|
0.2249 | 16.09M | 0 | -17.78M | -10.52M | -0.5492 |
|
VRTX
Vertex Pharmaceuticals Inc
|
453.36 | 115.12B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
771.87 | 81.34B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
397.65 | 52.48B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
840.95 | 51.59B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
174.04 | 37.13B | 447.02M | -1.18B | -906.14M | -6.1812 |
Fibrobiologics Inc Stock (FBLG) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2024-12-12 | Iniziato | Rodman & Renshaw | Buy |
| 2024-10-30 | Iniziato | H.C. Wainwright | Buy |
| 2024-09-24 | Iniziato | Maxim Group | Buy |
Fibrobiologics Inc Borsa (FBLG) Ultime notizie
FibroBiologics files IND application for psoriasis treatment - Investing.com India
FibroBiologics Announces IND Filing for CYPS317 Therapy for Moderate to Severe Psoriasis - Quiver Quantitative
Fibrobiologics stock rises after FDA filing for psoriasis treatment - Investing.com
Experimental cell therapy for hard-to-treat psoriasis moves to FDA review - Stock Titan
Why FibroBiologics Inc. stock remains resilientPortfolio Value Report & Entry Point Strategy Guides - Улправда
Activity Recap: Why FibroBiologics Inc. (SG0) stock attracts wealthy investorsJuly 2025 Analyst Calls & Long-Term Capital Growth Ideas - Улправда
Will FibroBiologics Inc. stock gain from strong economy2025 Pullback Review & Free Safe Capital Growth Stock Tips - Улправда
Is FibroBiologics Inc. stock supported by strong cash flows2025 Macro Impact & AI Powered Market Entry Strategies - Улправда
How strong is FibroBiologics Inc. stock revenue growthOptions Play & Momentum Based Trading Ideas - Улправда
Can FibroBiologics Inc. (SG0) stock hold up in economic slowdownMarket Sentiment Summary & Risk Controlled Daily Trade Plans - Bölüm Sonu Canavarı
Market Fear: Why FibroBiologics Inc. stock is in analyst buy zoneJuly 2025 Technicals & Consistent Growth Equity Picks - Улправда
Will FibroBiologics Inc. stock reach all time highs in 2025Trade Performance Summary & Fast Gain Stock Tips - ulpravda.ru
Why FibroBiologics Inc. (SG0) stock attracts wealthy investorsInsider Buying & Real-Time Stock Entry Alerts - Улправда
What drives FibroBiologics Inc stock pricePrice Action Analysis & Low Cost Wealth Plans - earlytimes.in
How interest rate cuts could boost FibroBiologics Inc. stockStock Surge & Stock Market Timing Techniques - Улправда
FibroBiologics (NASDAQ: FBLG) seeks reverse split and warrant share votes - Stock Titan
FibroBiologics prices 5.23M shares at 33c in registered direct offering - MSN
FibroBiologics closes $1.7 million registered direct offering By Investing.com - Investing.com Australia
Quarterly Earnings: Why analysts remain bullish on FibroBiologics Inc stockStop Loss & Daily Entry Point Alerts - moha.gov.vn
FibroBiologics closes $1.7 million registered direct offering - Investing.com
FibroBiologics Announces Closing of $1.7 Million Registered Direct Offering and Private Placement of Unregistered Warrants - Quiver Quantitative
FibroBiologics Announces Closing of $1.7 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules - GlobeNewswire
FibroBiologics enters securities purchase agreement - MSN
Biotech targeting chronic diseases raises $1.7M in stock sale - Stock Titan
FibroBiologics announces $1.7M registered direct offering - MSN
FibroBiologics Enters Securities Purchase Agreement - TipRanks
FibroBiologics (NASDAQ: FBLG) sells 5.2M shares at $0.33 with paired warrants - Stock Titan
Hedge Fund and Insider Trading News: AQR Capital Management, Bridgewater Associates, Shiprock Capital Management, Totus Capital, Sage Capital, Global Payments Inc (GPN), FibroBiologics Inc. (FBLG), and More - Insider Monkey
FibroBiologics raises $1.7 million in registered direct offering By Investing.com - Investing.com Nigeria
FibroBiologics raises $1.7 million in registered direct offering - Investing.com India
Fibrobiologics prices $1.7 million direct offering on Nasdaq - marketscreener.com
Fibrobiologics Prices $1.7 Million Direct Offering on Nasdaq - TradingView — Track All Markets
FibroBiologics (Nasdaq: FBLG) prices $1.7M direct sale and related $1.7M warrants - Stock Titan
FibroBiologics submits new patent application with USPTO - MSN
FibroBiologics Stock Surges 54%, With A 7-Day Winning Spree - Trefis
Major Stock Acquisition: Insider Buys Big in FibroBiologics! - TipRanks
Garcia, FibroBiologics general counsel, buys $47,600 in stock By Investing.com - Investing.com Australia
Garcia, FibroBiologics general counsel, buys $47,600 in stock - Investing.com
Officer Garcia Buys 140,000 ($47.6K) Of FibroBiologics Inc [FBLG] - TradingView — Track All Markets
FibroBiologics Director Ruben A. Garcia Acquires 140,000 Shares - TradingView — Track All Markets
FibroBiologics (NASDAQ:FBLG) Trading 4.8% Higher – What’s Next? - Defense World
FibroBiologics files patent for fibroblast therapy in joint repair By Investing.com - Investing.com Nigeria
Why Is FibroBiologics Stock Trading Higher Today?FibroBiologics (NASDAQ:FBLG) - Benzinga
FibroBiologics files patent for fibroblast therapy in joint repair - Investing.com
FibroBiologics Submits New Patent Application for Fibroblast-Derived Therapy in Orthopedic and Musculoskeletal Conditions - Quiver Quantitative
FibroBiologics Files Patent Application Covering Novel - GlobeNewswire
FibroBiologics Files Patent Application Covering Novel Fibroblast-Based Chondrocyte Spheroid Platform for Orthopedic and Musculoskeletal Conditions - The Manila Times
FibroBiologics Inc (FBLG) shows promising results - uspostnews.com
Does FibroBiologics Inc (FBLG) offer a good opportunity for investors? - Setenews
FibroBiologics announces payoff of outstanding debt - MSN
Will FibroBiologics Inc. (SG0) stock deliver stable dividendsRisk Management & Expert Approved Momentum Trade Ideas - Newser
Fibrobiologics Inc Azioni (FBLG) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Fibrobiologics Inc Azioni (FBLG) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| Khoja Hamid | Chief Scientific Officer |
May 27 '25 |
Buy |
0.84 |
20,000 |
16,800 |
31,250 |
0.90%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):